Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Biocon Biopharmaceuticals Limited, was an unlisted public company incorporated on 17 June, 2002. It is classified as a public limited company and is located in , Karnataka. It's authorized share capital was INR 44.00 cr and the total paid-up capital was INR 17.60 cr.
The current status of Biocon Biopharmaceuticals Limited is - Amalgamated.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2024 numbers.
Tofler currently has no financial reports
for this company due to a lack of available
information. This may be because the company
is dormant or closed (see company status)
or because it was formed only recently
(check the incorporation date) and financial data
is not yet available.
You can view basic information by scrolling through the page.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Kiran Mazumdar Shaw | 00347229 | 23 years |
Director | John Mccallum Marshall Shaw | 00347250 | 23 years |
Director | Chinappa Muckatira Bhemaiah | 01553650 | 18 years |
Director | Arun Suresh Chandavarkar | 01596180 | 18 years |
Kmp | Sridevi Bhamidipati | <HIDDEN> | 20 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
CLINIGENE INTERNATIONAL LIMITED |
Amalgamated
|
5.0 L | 3 | Karnataka |
CSEP RESEARCH FOUNDATION |
Active
|
1.0 L | 1 | Delhi |
IMMUNEEL THERAPEUTICS PRIVATE LIMITED |
Active
|
4.6 L | 1 | Karnataka |
NARAYANA VAISHNO DEVI SPECIALTY HOSPITALS PRIVATE LIMITED |
Active
|
1.0 Cr | 1 | Karnataka |
BIOCON RESEARCH LIMITED |
Active
|
5.0 L | 3 | Karnataka |
BIOCON BIOSPHERE LIMITED |
Active
|
288.6 Cr | 1 | Karnataka |
SCIENCE GALLERY BENGALURU |
Active
|
0.0 | 1 | Karnataka |
BIOFUSION THERAPEUTICS LIMITED |
Active
|
5.0 L | 1 | Karnataka |
GLENLOCH PROPERTIES LLP |
Active
|
1.0 L | 1 | Karnataka |
MAZUMDAR SHAW MEDICAL FOUNDATION |
Active
|
1.0 L | 1 | Karnataka |
NARAYANA HRUDAYALAYA LIMITED |
Active
|
204.4 Cr | 1 | Karnataka |
BIOCON BIOLOGICS LIMITED |
Active
|
1,758.3 Cr | 2 | Karnataka |
BIOCON LIMITED |
Active
|
600.3 Cr | 1 | Karnataka |
BIOCON PHARMA LIMITED |
Active
|
887.1 Cr | 1 | Karnataka |
BIOCON ACADEMY |
Active
|
5.0 L | 1 | Karnataka |
TRENT LIMITED |
Active
|
35.5 Cr | 1 | Maharashtra |
SYNGENE INTERNATIONAL LIMITED |
Active
|
402.5 Cr | 1 | Karnataka |
MYNVAX PRIVATE LIMITED |
Active
|
6.0 L | 1 | Karnataka |
Read more
The incorporation date of BIOCON BIOPHARMACEUTICALS LIMITED is 17 June, 2002
The authorized share capital of BIOCON BIOPHARMACEUTICALS LIMITED is INR ₹ 44.0 Cr.
The paid-up capital of BIOCON BIOPHARMACEUTICALS LIMITED is INR ₹ 17.6 Cr.
The registered address of BIOCON BIOPHARMACEUTICALS LIMITED is 20TH KM HOSUR ROAD,ELECTRONIC CITY P O BANGALORE BANGALORE Bangalore Karnataka - 560100
The CIN number of BIOCON BIOPHARMACEUTICALS LIMITED is U24231KA2002PLC030643.